Citigroup’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-4,724
| Closed | -$12.8K | – | 4838 |
|
|
2023
Q4 | $12.8K | Buy |
+4,724
| New | +$12.8K | ﹤0.01% | 4374 |
|
|
2021
Q3 | – | Sell |
-500
| Closed | -$4K | – | 5114 |
|
|
2021
Q2 | $4K | Hold |
500
| – | – | ﹤0.01% | 5189 |
|
|
2021
Q1 | $6K | Buy |
+500
| New | +$6K | ﹤0.01% | 5177 |
|
|
2016
Q1 | – | Sell |
-7
| Closed | -$1K | – | 5381 |
|
|
2015
Q4 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 5230 |
|
|
2015
Q3 | – | Sell |
-15
| Closed | -$4K | – | 5292 |
|
|
2015
Q2 | $4K | Buy |
+15
| New | +$4K | ﹤0.01% | 4933 |
|